Tinción de Leishman, 5 g

2-[2-(4-ethoxyphenyl)-1H-1,3-benzodiazol-6-yl]-6-(4-methylpiperazin-1-yl)-1H-1,3-benzodiazole trihydrochloride, 98%, 10mg

Ethyl 2-amino-2-phenylacetate hydrochloride, 95.0%, 500g

Tris[3,5-bis(trifluoromethyl)phenyl]phosphine>98.0%(GC)5g

Carbonato de praseodimio hidrato en polvo 98+% 250 g

4-Phenoxyphthalic acid, 97.0%, 250mg

3,3,3',3'-Tetramethyl-2,2',3,3'-tetrahydro-1,1'-spirobi[indene]-6,6'-diol, 95.0%, 25g

N-(3-formylphenyl)benzenesulfonamide, 1g

3,5,5-trimethyl-2-pyrrolidinone, 95.0%, 1g

5-Amino-3-phenylisoxazole>98.0%(HPLC)(N)1g

2-Chloro-9-phenyl-1,10-phenanthroline, 97%, 5g

3-Butyl-1-methyl-1H-imidazol-3-ium hydrogensulfate, 97.0%, 100g

Methyl 6-bromo-2-chloronicotinate, 95.0%, 250mg